Uscom Ltd
ASX:UCM
Uscom Ltd
Operating Income
Uscom Ltd
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Uscom Ltd
ASX:UCM
|
Operating Income
-AU$2.9m
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
Neurotech International Ltd
ASX:NTI
|
Operating Income
-AU$7.8m
|
CAGR 3-Years
-82%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
ImpediMed Ltd
ASX:IPD
|
Operating Income
-AU$20.7m
|
CAGR 3-Years
0%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-12%
|
|
C
|
Cyclopharm Ltd
ASX:CYC
|
Operating Income
-AU$8.6m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-119%
|
CAGR 10-Years
-25%
|
Cochlear Ltd
ASX:COH
|
Operating Income
AU$491.1m
|
CAGR 3-Years
36%
|
CAGR 5-Years
6%
|
CAGR 10-Years
15%
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
Operating Income
-AU$3.8m
|
CAGR 3-Years
2%
|
CAGR 5-Years
-35%
|
CAGR 10-Years
N/A
|
See Also
What is Uscom Ltd's Operating Income?
Operating Income
-2.9m
AUD
Based on the financial report for Jun 30, 2023, Uscom Ltd's Operating Income amounts to -2.9m AUD.
What is Uscom Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
-8%
Over the last year, the Operating Income growth was -15%. The average annual Operating Income growth rates for Uscom Ltd have been -31% over the past three years , -8% over the past five years .